Long-term clinical and functional results of magnetic sphincter augmentation
Diseases of the Esophagus · 2023
DOI: 10.1093/dote/doac109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2023. Verfasst von Inanc S Sarici und 4 weiteren Autor:innen. Beteiligte Einrichtung: Esophageal Institute, Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Deglutition Disorders, Laparoscopy, Gastroesophageal Reflux. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Magnetic sphincter augmentation (MSA) was introduced in 2007 as an alternative surgical procedure for patients with gastroesophageal reflux disease (GERD). The majority of data since MSA’s introduction has focused on short and intermediate-term results, demonstrating safety and high efficacy in terms of reflux symptom control, freedom from proton pump inhibitor use and normalization of distal esophageal acid exposure. However, GERD is a chronic condition that demands a long-term solution. Limited available data from studies reporting outcomes at 5 years or later following MSA demonstrate that the promising short- and mid-term efficacy and safety profile of MSA remains relatively constant in the long term. Compared with Nissen fundoplication, MSA has a much lower rate of gas-bloat and inability to belch at a short-term follow-up, a difference that persists in the long-term. The most common complaint after MSA at a short-term follow-up is dysphagia. However, limited data suggest dysphagia rates largely decrease by 5 years. Dysphagia is the most common indication for dilation and device removal in both early- and long-term studies. However, the overall rates of dilation and removal are similar in short- and long-term reports, suggesting the majority of these procedures are performed in the short-term period after device implantation. The indications and standard practices of MSA have evolved over time. Long-term outcome data currently available are all from patient cohorts who were selected for MSA under early restricted indications and outdated regimens. Therefore, further long-term studies are needed to corroborate the preliminary, yet encouraging long-term results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Esophageal Institute, Department of Surgery, Allegheny Health Network, Pittsburgh, PA, USA.
- Department of Surgery, Drexel University, Philadelphia, PA, USA.
ORCID-Profile: Shahin Ayazi
Zitieren
APA
Sarici, I. S., Dunn, C. P., Eriksson, S. E., Jobe, B. A., & Ayazi, S. (2023). Long-term clinical and functional results of magnetic sphincter augmentation. Diseases of the Esophagus. https://doi.org/10.1093/dote/doac109
Vancouver
Sarici IS, Dunn CP, Eriksson SE, Jobe BA, Ayazi S. Long-term clinical and functional results of magnetic sphincter augmentation. Diseases of the Esophagus. 2023. doi:10.1093/dote/doac109
BibTeX
@article{Sarici2023,
author = {Sarici, Inanc S and Dunn, Colin P and Eriksson, Sven E and Jobe, Blair A and Ayazi, Shahin},
title = {Long-term clinical and functional results of magnetic sphincter augmentation},
journal = {Diseases of the Esophagus},
year = {2023},
doi = {10.1093/dote/doac109}
}
EUVIMED